Accolade To Present at Upcoming Investor Conferences
Get Alerts ACCD Hot Sheet
Join SI Premium – FREE
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:
- Raymond James 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5 at 8:05 am ET
- Barclays 26th Annual Global Healthcare Conference in Miami Beach on Wednesday, March 13 at 1:35 pm ET
A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days.
About Accolade, Inc.
Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, Twitter, Instagram and Facebook.
Investor Contact:
Todd Friedman, Investor Relations, [email protected]
Source: Accolade
Source: Accolade, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- Polygon Joins Digital Pound Lab as XRP Rallies, Best Altcoin To Buy Now AlphaPepe Builds Toward Launch
- BNB News: BNB Nears $669, LINK Hits 7-Month High – But the Next Crypto to Explode May Be a New Presale
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Raymond James, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share